Denosumab for Elderly Men with Osteoporosis: A Cost-Effectiveness Analysis from the US Payer Perspective
Summary
Denosumab for Elderly Men with Osteoporosis: A Cost-Effectiveness Analysis from the US Payer Perspective is a scholarly article[1].
Key Facts
Denosumab for Elderly Men with Osteoporosis: A Cost-Effectiveness Analysis from the US Payer Perspective's instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). Denosumab for Elderly Men with Osteoporosis: A Cost-Effectiveness Analysis from the US Payer Perspective. Retrieved May 24, 2026, from https://4ort.xyz/entity/denosumab-for-elderly-men-with-osteoporosis-a-cost-effectiveness-analysis-from-the-us-payer-perspective
MLA“Denosumab for Elderly Men with Osteoporosis: A Cost-Effectiveness Analysis from the US Payer Perspective.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/denosumab-for-elderly-men-with-osteoporosis-a-cost-effectiveness-analysis-from-the-us-payer-perspective.
BibTeX@misc{4ortxyz_denosumab-for-elderly-men-with-osteoporosis-a-cost-effectiveness-analysis-from-the-us-payer-perspective_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Denosumab for Elderly Men with Osteoporosis: A Cost-Effectiveness Analysis from the US Payer Perspective}}, year = {2026}, url = {https://4ort.xyz/entity/denosumab-for-elderly-men-with-osteoporosis-a-cost-effectiveness-analysis-from-the-us-payer-perspective}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Denosumab for Elderly Men with Osteoporosis: A Cost-Effectiveness Analysis from the US Payer Perspective — https://4ort.xyz/entity/denosumab-for-elderly-men-with-osteoporosis-a-cost-effectiveness-analysis-from-the-us-payer-perspective (retrieved 2026-05-24)
